Combination immunotherapy targets cancer resistance
Researchers have identified an experimental antibody that overcomes resistance to treatment by targeting a wider range of immune cells linked to tumor growth.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Cancer | Cancer & Oncology | Immunotherapy | Science | Universities & Medical Training | Yale